Speakers and Sessions

Please note: this page will be regularly updated with complete information surrounding confirmed Chairs, Speakers and corresponding talks.

Plenary Lectures

Opening Plenary Lecture 1
New challenges in calcium and phosphate metabolism
Keith Hruska, USA

Plenary Lecture 2
Physiology of renal and intestinal divalent ion transport
René Bindels, The Netherlands

Plenary Lecture 3
Novel aspects of genetic diseases of bone and kidney
Rajesh V Thakker, UK

Plenary Lecture 4
Calcimimetics
Steven Hebert, USA

Plenary Lecture 5
Bone-kidney axis and vascular calcification
Catherine M Shanahan, UK

Plenary Lecture 6
Stem cells, PTH and bone
Paolo Bianco, Italy

Basic science sessions

1. Transporters (structure – function interactions, proteins)
   Chair: René Bindels, The Netherlands
   • The epithelial calcium channels: uniquely regulated gatekeepers
     René Bindels, The Netherlands
   • Epithelial phospate transporters
     Jürg Biber, Switzerland
   • Is Paracellin-1 (CLAUDIN-16) only involved in cation transport?
     Martin Konrad, Germany
     
2. Receptors and cellular mechanisms of regulation
   Chair: Steven Hebert, USA
   • Calcium-sensing receptors
     L Darryl Quarles, USA
   • Molecular and physiologic consequences of genetic alterations in the 25-hydroxyvitamin D3 1α hydroxylase and the vitamin D receptor
     David Goltzman, Canada
   • Parathyroid cell biology in chronic renal failure
     Mariano Rodriguez, Spain
     
3. Phosphatonins (genetics, animal models)
   Chair: Rajiv Kumar, USA
   • FGF-23: from cloning to function
     Takeyoshi Yamashita, Japan
   • Frizzled-related protein-4 and MEPE in phosphate homeostasis
     Rajiv Kumar, USA
   • Klotho: bone, kidney, vessels and the ageing process
     Makoto Kuro-O, USA

Clinical sessions

1. Genetic diseases of bone and kidney
   Chair: Gérard Friedlander, France
   • The role of the PTH/PTHrP receptor in health and disease
     Caroline Silve, France
   • ClC-7 and Ostm1: an ion transport complex important for osteoclasts and lysosomes of the CNS and the kidney
     Thomas J Jentsch, Germany
   • Disorders of alkaline phosphatases and bone/mineral disease
     Michael P Whyte, USA
     
2. Osteoporosis and renal osteodystrophy
   Chair: Klaus Ølgaard, Denmark
   • Osteoporosis: assessment of fracture risk
     Susan Ott, USA
   • The new renal osteodystrophy: CKD-MBD (mineral bone disorder)
     Sharon Moe, USA
   • Is there a role for bisphosphonates in the treatment of renal bone disease?
     Paul Miller, USA
     
3. Relation between bone/mineral metabolism disturbances and cardiovascular disease in CKD and management
   Chair: Eberhard Ritz, Germany
   • Role of FGF-23 in CKD
     Masafumi Fukagawa, Japan
   • Bone histomorphometry and vascular dysfunction
     Gérard London, France
   • Vitamin D versus calcimimetics in control of secondary hyperparathyroidism
     Klaus Ølgaard, Denmark

Translational sessions

1. Urinary infection and nephrolithiasis
   Chair: David Bushinsky, USA
   • Tamm-Horsfall protein-Uromodulin: new ideas about an old molecule
     Olivier Devuyst, Belgium
   • Hypercalciuria: from animal models to human disease
     David Bushinsky, USA
   • Sodium phosphate transporters, nephrolithiasis and bone demineralization
     Dominique Prié, France
     
2. Molecular aspects of mineral metabolism diseases
   Chair: Rajesh V Thakker, UK
   • Dent disease and related disorders
     Steven J Scheinman, USA
   • Pseudohypoparathyroidism, McCune Albright syndrome and the GS alpha mutations
     Harald Jueppner, USA
   • Nephrectomized CYP27B1-deficient mice as a model of vitamin D deficiency and uremia
     René St-Arnaud, Canada
     
3. Pediatric renal osteodystrophy: unique challenges in the growing skeleton
   Chair: Craig B Langman, USA
   • Dynamic aspects of bone growth in children with chronic kidney disease: lessons learned from innovative imaging techniques
     Mary Leonard, USA
   • Growth hormone and bone in chronic kidney disease
     Burkhard Tönshoff, Germany
   • Phosphate homeostasis in early chronic kidney disease in children: role of FGF-23
     Craig B Langman, USA
   • Effect of vitamin D treatment on parathyroid and bone in children
     Isidro Salusky, USA
   • Panel Discussion
     
4. Enzymes, growth factors and hormones : physiological roles and contributions to kidney and bone diseases
   Chair: Jürgen Floege, Germany
   • PTH and PTHrP: from mouse to man
     Ewa Lewin, Denmark
   • Pathogenesis of vascular calcification: experimental studies in vitro and in vivo
     Dwight A Towler, USA
   • Pathogenesis and treatment of vascular calcification in CKD patients
     Markus Ketteler, Germany